Patents by Inventor Yuanyuan YUAN

Yuanyuan YUAN has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Processes and intermediates for preparing a Btk inhibitor
    Patent number: 12215110
    Abstract: Disclosed is a process for the preparation of certain intermediates, e.g. a process for preparing a compound of formula (I) wherein, R1, R2 and X1 are as defined in the description, and which intermediate and processes are useful in the preparation of a BTK inhibitor, such as ibrutinib.
    Type: Grant
    Filed: May 20, 2020
    Date of Patent: February 4, 2025
    Assignee: Janssen Pharmaceutica NV
    Inventors: Philip James Pye, Andras Horvath, Cheng Yi Chen, Yuanyuan Yuan, Jinxiong Su, Shuo Wang, Simon Albert Wagschal
  • PROCESSES AND INTERMEDIATES FOR PREPARING A BTK INHIBITOR
    Publication number: 20220235058
    Abstract: Disclosed is a process for the preparation of certain intermediates, e.g. process for preparing a compound of formula (I) or a pharmaceutically acceptable salt thereof, in an enantioenriched form, which intermediate and processes are useful in the preparation of a BTK inhibitor, such as ibrutinib.
    Type: Application
    Filed: May 20, 2020
    Publication date: July 28, 2022
    Inventors: Philip James PYE, Andras HORVATH, Laurent LEFORT, Bernardus KAPTEIN, Gerardus Karel Maria VERZIJL, Yuanyuan YUAN, Jinxiong SU
  • PROCESSES AND INTERMEDIATES FOR PREPARING A BTK INHIBITOR
    Publication number: 20220204516
    Abstract: Disclosed is a process for the preparation of certain intermediates, e.g. a process R for preparing a compound of formula (I) wherein, R1, R2 and X1 are as defined in the description, and which intermediate and processes are useful in the preparation of a BTK inhibitor, such as ibrutinib.
    Type: Application
    Filed: May 20, 2020
    Publication date: June 30, 2022
    Inventors: Philip James PYE, Andras HORVATH, Cheng Yi CHEN, Yuanyuan Yuan, Jinxiong SU, Shuo WANG, Simon Albert WAGSCHAL
  • CRYSTAL FORM OF A NUCLEOSIDE INHIBITOR OF HCV
    Publication number: 20170165287
    Abstract: Provided are crystalline forms of the compound of formula (I), which is a nucleoside inhibitor of HCV, processes for the preparation thereof, and pharmaceutical compositions comprising these crystalline forms.
    Type: Application
    Filed: November 28, 2013
    Publication date: June 15, 2017
    Inventors: Jennifer ALBANEZE-WALKER, Xianglu ZENG, Yuanyuan YUAN